XML 29 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment Information
 9 Months Ended
Sep. 30, 2022
Segment Reporting [Abstract]  
Segment Information SEGMENT INFORMATION
As previously disclosed, effective December 31, 2021 we changed our reportable business segments to (i) MedSurg and Neurotechnology and (ii) Orthopaedics and Spine to align to our new internal reporting structure. We have reflected these changes in all historical periods presented.
Three MonthsNine Months
2022202120222021
MedSurg and Neurotechnology$2,588 $2,349 $7,560 $6,899 
Orthopaedics and Spine1,891 1,811 5,687 5,508 
Net sales$4,479 $4,160 $13,247 $12,407 
MedSurg and Neurotechnology$626 $663 $1,838 $2,000 
Orthopaedics and Spine519 500 1,648 1,518 
Segment operating income$1,145 $1,163 $3,486 $3,518 
Items not allocated to segments:
Corporate and other
$(144)$(105)$(488)$(421)
Acquisition and integration-related costs78 (126)(108)(495)
Amortization of intangible assets
(159)(144)(469)(474)
Restructuring-related and other charges
(58)(178)(229)(209)
Medical device regulations
(38)(27)(98)(72)
Recall-related matters
4 (16)(14)(98)
Regulatory and legal matters
(20)7 (53)16 
Consolidated operating income$808 $574 $2,027 $1,765 
There were no significant changes to total assets by segment from information provided in our Annual Report on Form 10-K for 2021, other than the addition of the assets acquired in the Vocera acquisition which are included in the MedSurg and Neurotechnology segment.